Skip to content
Search

Latest Stories

Around 148,000 people in England had Covid-19 recently: ONS

Around 148,000 people in England had Covid-19 in recent weeks, according to results on Thursday (14) from a large-scale study in Britain into the spread of the disease.

The Office for National Statistics said it estimated that about 0.27 per cent of England's population were carrying the disease during the April 27 to May 10 survey period - slightly higher than an estimate of 0.24 per cent published on Monday (13).


But there is a wide range of uncertainty around the true number of people infected, which the ONS said could range from 94,000 to 222,000 at a standard 95 per cent confidence interval.

The estimate was based on swab tests performed on 10,705 people across 5,276 households, rather than in hospitals or care homes, the Office for National Statistics said.

England is slowly starting to ease coronavirus restrictions - including encouraging more people to return to work - but like many countries has said it needs to ensure this does not accelerate the spread of the disease.

More than 40,000 people in the United Kingdom have died with suspected Covid-19, the highest official toll in Europe.

While the disease caused by the novel coronavirus hits older people hardest, the survey found there was little difference between age groups in terms of the spread of the virus.

The ONS survey was conducted with the University of Oxford, the University of Manchester, Public Health England and Wellcome Trust.

(Reuters)

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less